Biofourmis Singapore Pte. Ltd

Biofourmis Singapore Pte. Ltd has 2 AI-enabled medical devices on the FDA list. The first decision was on March 7, 2019 and the most recent on August 15, 2019 (Biovitals Analytics Engine). Its most common review panel is Cardiovascular (2 devices).